{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:03:10Z","timestamp":1778857390854,"version":"3.51.4"},"reference-count":63,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["PI13\/01809  Acci\u00f3n Estrat\u00e9gica en Salud"],"award-info":[{"award-number":["PI13\/01809  Acci\u00f3n Estrat\u00e9gica en Salud"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["PI13\/02153 Acci\u00f3n Estrat\u00e9gica en Salud"],"award-info":[{"award-number":["PI13\/02153 Acci\u00f3n Estrat\u00e9gica en Salud"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16CIII\/00012 Acci\u00f3n Estrat\u00e9gica en Salud"],"award-info":[{"award-number":["PI16CIII\/00012 Acci\u00f3n Estrat\u00e9gica en Salud"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG20714"],"award-info":[{"award-number":["IG20714"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2017-0535"],"award-info":[{"award-number":["2017-0535"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Class I phosphoinositide 3-kinases (PI3K) are involved in the development of normal and autoimmune responses, including Experimental Autoimmune Encephalomyelitis (EAE), a mouse model for human multiple sclerosis (MS). Here, the role of the ubiquitously expressed class IA PI3K p110\u03b1 catalytic subunits in EAE has been analyzed using a model of Cre\/flox mediated T cell specific deletion of p110\u03b1 catalytic chain (p110\u03b1\u0394T). Comparison of two month-old (young) and six month-old (mature) p110\u03b1\u0394T mice and their wild type (WT) counterparts indicated loss of spleen CD4+ T cells that increased with age, indicating a role of p110\u03b1 in their homeostasis. In contrast, CD4+ T regulatory (Treg) cells were enhanced in mature p110\u03b1\u0394T mice when compared to WT mice. Since Myelin Oligodendrocyte Glycoprotein (MOG) peptide-induced EAE is dependent on, or mediated by CD4+ T cells and CD4+ T cell-derived cytokines and controlled by Treg cells, development of EAE in young and mature WT or p110\u03b1\u0394T mice was analyzed. EAE clinical symptoms and disease scores in six month p110\u03b1\u0394T mice were significantly lower than those of mature WT, or young WT and p110\u03b1\u0394T mice. Furthermore, ex vivo antigen activation of lymph node cells from MOG immunized mature p110\u03b1\u0394T mice induced significantly lower levels of IFN-\u03b3 and IL-17A than young p110\u03b1\u0394T or young and mature WT mice. Other cytokines including IL-2, IL-10 or TNF-\u03b1 showed no significant differences between p110\u03b1\u0394T and WT mature mice. Our data show a lower incidence of MOG-induced EAE in mature p110\u03b1\u0394T mice linked to altered T cell homeostasis and lower secretion of inflammatory cytokines.<\/jats:p>","DOI":"10.3390\/ijms22168698","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:22:38Z","timestamp":1628846558000},"page":"8698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PI3-Kinase p110\u03b1 Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9032-0072","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Rojo","sequence":"first","affiliation":[{"name":"Departamento de Biomedicina Molecular, Centro de Investigaciones Biol\u00f3gicas Margarita Salas, CSIC, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-7734","authenticated-orcid":false,"given":"Mar\u00eda","family":"Montes-Casado","sequence":"additional","affiliation":[{"name":"Unidad de Inmunolog\u00eda Celular, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Aragoneses-Fenoll","sequence":"additional","affiliation":[{"name":"Unidad de Inmunolog\u00eda Celular, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Ojeda","sequence":"additional","affiliation":[{"name":"Unidad de Inmunolog\u00eda Celular, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Dianzani","sequence":"additional","affiliation":[{"name":"Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Department of Health Sciences, University of Piemonte Orientale (UPO), 28100 Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-0835","authenticated-orcid":false,"given":"Pilar","family":"Portol\u00e9s","sequence":"additional","affiliation":[{"name":"Unidad de Inmunolog\u00eda Celular, Centro Nacional de Microbiolog\u00eda, Instituto de Salud Carlos III, Majadahonda, 28220 Madrid, Spain"},{"name":"Presidencia, Consejo Superior de Investigaciones Cient\u00edficas (CSIC), 28006 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple Sclerosis: Mechanisms and immunotherapy","volume":"97","author":"Kaskow","year":"2018","journal-title":"Neuron"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of Multiple Sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e20190460","DOI":"10.1084\/jem.20190460","article-title":"Pathogenic T cell cytokines in multiple sclerosis","volume":"217","author":"Wagner","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1016\/j.febslet.2011.03.064","article-title":"Cytokines and effector T cell subsets causing autoimmune CNS disease","volume":"585","author":"Petermann","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system","volume":"175","author":"McGeachy","year":"2005","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/intimm\/dxh390","article-title":"Recovery from experimental allergic encephalomyelitis is TGF-\u03b2 dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells","volume":"18","author":"Zhang","year":"2006","journal-title":"Int. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13317-018-0109-x","article-title":"Regulatory B and T lymphocytes in multiple sclerosis: Friends or foes?","volume":"9","author":"Vasileiadis","year":"2018","journal-title":"Auto. Immun. Highlights"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.4049\/jimmunol.173.2.828","article-title":"IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice","volume":"173","author":"Anderson","year":"2004","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.173.1.157","article-title":"The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine Experimental Autoimmune Encephalomyelitis","volume":"173","author":"Greve","year":"2004","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.4049\/jimmunol.175.11.7341","article-title":"The ICOS molecule plays a crucial role in the development of mucosal tolerance","volume":"175","author":"Miyamoto","year":"2005","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.0901233","article-title":"IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells","volume":"183","author":"Pot","year":"2009","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/intimm\/dxn016","article-title":"CD4+ICOS+ T lymphocytes inhibit T cell activation \u2018in vitro\u2019 and attenuate autoimmune encephalitis \u2018in vivo\u2019","volume":"20","author":"Rojo","year":"2008","journal-title":"Int. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.4049\/jimmunol.2000599","article-title":"A case for Phosphoinositide 3-Kinase\u2013targeted therapy for infectious disease","volume":"205","author":"Adefemi","year":"2020","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","article-title":"PI3K inhibitors in inflammation, autoimmunity and cancer","volume":"23","author":"Stark","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1874312901206010245","article-title":"The therapeutic potential for PI3K inhibitors in autoimmune rheumatic diseases","volume":"6","author":"Clatworthy","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrm2882","article-title":"The emerging mechanisms of isoform-specific PI3K signalling","volume":"11","author":"Vanhaesebroeck","year":"2010","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"a002428","DOI":"10.1101\/cshperspect.a002428","article-title":"Lipid signaling in T-cell development and function","volume":"2","author":"Huang","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-065X.2008.00750.x","article-title":"Fine tuning the immune response with PI3K","volume":"228","author":"Fruman","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri2036","article-title":"PI3K\u03b4 and PI3K\u03b3: Partners in crime in inflammation in rheumatoid arthritis and beyond?","volume":"7","author":"Rommel","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.22.012703.104721","article-title":"Phosphoinositide 3-Kinase: Diverse roles in immune cell activation","volume":"22","author":"Deane","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni0403-313","article-title":"The role of PI3K in immune cells","volume":"4","author":"Koyasu","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.177.8.5122","article-title":"The p110\u03b4 isoform of Phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells","volume":"177","author":"Okkenhaug","year":"2006","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2007-04-086751","article-title":"Inactivation of PI3K\u03b3 and PI3K\u03b4 distorts T-cell development and causes multiple organ inflammation","volume":"110","author":"Ji","year":"2007","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.0901099","article-title":"The p110\u03b4 isoform of Phosphatidylinositol 3-Kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells","volume":"183","author":"Liu","year":"2009","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.4049\/jimmunol.0801352","article-title":"PI3K p110\u03b2 positively regulates Lipopolysaccharide-induced IL-12 production in human macrophages and dendritic cells and JNK1 plays a novel role","volume":"182","author":"Utsugi","year":"2009","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaut.2011.02.006","article-title":"PI3K\u03b4 drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation","volume":"36","author":"Comerford","year":"2011","journal-title":"J. Autoimmun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4049\/jimmunol.1301533","article-title":"Innate PI3K p110\u03b4 regulates Th1\/Th17 development and microbiota-dependent colitis","volume":"192","author":"Steinbach","year":"2014","journal-title":"J. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2016.02.005","article-title":"ETP-46321, a dual p110\u03b1\/\u03b4 class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis","volume":"106","author":"Ojeda","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.3389\/fimmu.2018.00332","article-title":"T-cell specific loss of the PI-3 kinase p110\u03b1 catalytic subunit results in enhanced cytokine production and anti tumor response","volume":"9","author":"Ojeda","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"fty053","DOI":"10.1093\/femspd\/fty053","article-title":"The p110\u03b4 Isoform of Phosphatidylinositol 3-Kinase plays an important role in host defense against Chlamydial lung infection through influencing CD4+ T cell function","volume":"76","author":"Qiao","year":"2018","journal-title":"Pathog. Dis."},{"key":"ref_33","first-page":"1387","article-title":"Targeting the class IA PI3K isoforms p110\u03b1\/\u03b4 attenuates heart allograft rejection in mice by suppressing the CD4+ T lymphocyte response","volume":"10","author":"Yang","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.4049\/jimmunol.177.10.6598","article-title":"Cutting edge: The phosphoinositide 3-kinase p110\u03b4 is critical for the function of CD4+CD25+Foxp3+ regulatory T cells","volume":"177","author":"Patton","year":"2006","journal-title":"J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature13444","article-title":"Inactivation of PI(3)K p110\u03b4 breaks regulatory T-cell-mediated immune tolerance to cancer","volume":"510","author":"Ali","year":"2014","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e120626","DOI":"10.1172\/jci.insight.120626","article-title":"Phosphoinositide 3-kinase \u03b4 inhibition promotes antitumor responses but antagonizes checkpoint inhibitors","volume":"3","author":"Lim","year":"2018","journal-title":"JCI Insight"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4049\/jimmunol.1701703","article-title":"The PI3K p110\u03b4 isoform inhibitor Idelalisib preferentially inhibits human regulatory T cell function","volume":"202","author":"Chellappa","year":"2019","journal-title":"J. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.208397","article-title":"Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase \u03b4","volume":"104","author":"David","year":"2019","journal-title":"Haematologica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4049\/jimmunol.2000043","article-title":"Loss of phosphatidylinositol 3-kinase activity in regulatory T cells leads to neuronal inflammation","volume":"205","author":"Stark","year":"2020","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/BST0340647","article-title":"Signalling through Class I PI3Ks in mammalian cells","volume":"34","author":"Hawkins","year":"2006","journal-title":"Biochem. Soc. Transac."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1007\/s00018-010-0606-1","article-title":"Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278)","volume":"68","author":"Acosta","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nature06892","article-title":"Angiogenesis selectively requires the p110\u03b1 isoform of PI3K to control endothelial cell migration","volume":"453","author":"Graupera","year":"2008","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/039463201402700108","article-title":"Suppression of CD4+ T lymphocyte activation \u201cin vitro\u201d and experimental encephalomyelitis \u201cin vivo\u201d by the phosphatidyl inositol 3-kinase inhibitor PIK-75","volume":"27","author":"Acosta","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.174.4.2387","article-title":"Middle-Age male mice have increased severity of Experimental Autoimmune Encephalomyelitis and are unresponsive to testosterone therapy","volume":"174","author":"Matejuk","year":"2005","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.08.005","article-title":"Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood\u2013brain barrier permeability in middle-aged mice","volume":"287","author":"Seo","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/imm.12644","article-title":"Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice","volume":"149","author":"Peferoen","year":"2016","journal-title":"Immunology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","article-title":"Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection","volume":"40","author":"Crawford","year":"2014","journal-title":"Immunity"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.1501159","article-title":"Eomesodermin expression in CD4+ T cells restricts peripheral Foxp3 induction","volume":"195","author":"Lupar","year":"2015","journal-title":"J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1084\/jem.20170901","article-title":"Deficiency in T follicular regulatory cells promotes autoimmunity","volume":"215","author":"Fu","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4049\/jimmunol.180.2.774","article-title":"ICOS controls the pool size of effector-memory and regulatory T cells","volume":"180","author":"Burmeister","year":"2008","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2008.03.018","article-title":"Two functional subsets of Foxp3+ regulatory T cells in human thymus and periphery","volume":"28","author":"Ito","year":"2008","journal-title":"Immunity"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.mad.2009.08.006","article-title":"Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells","volume":"130","author":"Channappanavar","year":"2009","journal-title":"Mech. Ageing Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e20182232","DOI":"10.1084\/jem.20182232","article-title":"PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance","volume":"218","author":"Tan","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e20201142","DOI":"10.1084\/jem.20201142","article-title":"ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue","volume":"218","author":"Mittelsteadt","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Montes-Casado, M., Ojeda, G., Criado, G., Rojo, J.M., and Portol\u00e9s, P. (2021). The PI-3-kinase p110\u03b1 catalytic subunit of T lymphocytes modulates Collagen-Induced Arthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126405"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"ra60","DOI":"10.1126\/scisignal.2001104","article-title":"The PI3K isoforms p110\u03b1 and p110\u03b4 are essential for pre-B cell receptor signaling and B cell development","volume":"3","author":"Ramadani","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","article-title":"Th17 cells express Interleukin-10 receptor and are controlled by Foxp3- and Foxp3+ regulatory CD4+ T cells in an Interleukin-10-dependent manner","volume":"34","author":"Huber","year":"2011","journal-title":"Immunity"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","article-title":"A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival","volume":"15","author":"Lee","year":"2001","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1084\/jem.186.8.1233","article-title":"A critical role for Lymphotoxin in Experimental Allergic Encephalomyelitis","volume":"186","author":"Suen","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.142.12.4169","article-title":"Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation","volume":"142","author":"Portoles","year":"1989","journal-title":"J. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8698\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:45:19Z","timestamp":1760165119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/16\/8698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":63,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijms22168698"],"URL":"https:\/\/doi.org\/10.3390\/ijms22168698","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}